ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981